These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 8986534)
1. Expression of epidermal growth factor-related proteins and epidermal growth factor receptor in common epithelial ovarian tumors. Niikura H; Sasano H; Sato S; Yajima A Int J Gynecol Pathol; 1997 Jan; 16(1):60-8. PubMed ID: 8986534 [TBL] [Abstract][Full Text] [Related]
2. Immunolocalization of epidermal growth factor receptor and c-erbB-2 oncogene product in human ovarian carcinoma. Ito K; Sasano H; Ozawa N; Sato S; Silverberg SG; Yajima A Int J Gynecol Pathol; 1992 Oct; 11(4):253-7. PubMed ID: 1356938 [TBL] [Abstract][Full Text] [Related]
3. Frequent immunohistochemical detection of EGF supergene family members in ovarian carcinogenesis. Stromberg K; Johnson GR; O'Connor DM; Sorensen CM; Gullick WJ; Kannan B Int J Gynecol Pathol; 1994 Oct; 13(4):342-7. PubMed ID: 7814196 [TBL] [Abstract][Full Text] [Related]
4. Expression of epidermal growth factor family proteins and epidermal growth factor receptor in human endometrium. Niikura H; Sasano H; Kaga K; Sato S; Yajima A Hum Pathol; 1996 Mar; 27(3):282-9. PubMed ID: 8600044 [TBL] [Abstract][Full Text] [Related]
5. Significance of tyrosine kinase activity on malign transformation of ovarian tumors: a comparison between EGF-R and TGF-alpha. Zeren T; Inan S; Seda Vatansever H; Ekerbicer N; Sayhan S Acta Histochem; 2008; 110(3):256-63. PubMed ID: 18054376 [TBL] [Abstract][Full Text] [Related]
6. Association of cortactin, fascin-1 and epidermal growth factor receptor (EGFR) expression in ovarian carcinomas: correlation with clinicopathological parameters. Lin CK; Su HY; Tsai WC; Sheu LF; Jin JS Dis Markers; 2008; 25(1):17-26. PubMed ID: 18776588 [TBL] [Abstract][Full Text] [Related]
7. Clinical significance of oncogenes and growth factors in ovarian carcinomas. Bauknecht T; Birmelin G; Kommoss F J Steroid Biochem Mol Biol; 1990 Dec; 37(6):855-62. PubMed ID: 2285597 [TBL] [Abstract][Full Text] [Related]
8. SATB2 Expression Distinguishes Ovarian Metastases of Colorectal and Appendiceal Origin From Primary Ovarian Tumors of Mucinous or Endometrioid Type. Moh M; Krings G; Ates D; Aysal A; Kim GE; Rabban JT Am J Surg Pathol; 2016 Mar; 40(3):419-32. PubMed ID: 26551622 [TBL] [Abstract][Full Text] [Related]
9. Impact of the expression of epidermal growth factor, transforming growth factor alpha, and epidermal growth factor receptor on the prognosis of superficial bladder cancer. Türkeri LN; Erton ML; Cevik I; Akdaş A Urology; 1998 Apr; 51(4):645-9. PubMed ID: 9586623 [TBL] [Abstract][Full Text] [Related]
10. Stage-specific embryonic antigen 4 expression in epithelial ovarian carcinoma. Ye F; Li Y; Hu Y; Zhou C; Hu Y; Chen H Int J Gynecol Cancer; 2010 Aug; 20(6):958-64. PubMed ID: 20683402 [TBL] [Abstract][Full Text] [Related]
11. Mitogenic effects of epidermal growth factor and transforming growth factor-alpha on EGF-receptor positive human ovarian carcinoma cell lines. Crew AJ; Langdon SP; Miller EP; Miller WR Eur J Cancer; 1992; 28(2-3):337-41. PubMed ID: 1591048 [TBL] [Abstract][Full Text] [Related]
12. Expression of the imprinted H19 oncofetal RNA in epithelial ovarian cancer. Tanos V; Prus D; Ayesh S; Weinstein D; Tykocinski ML; De-Groot N; Hochberg A; Ariel I Eur J Obstet Gynecol Reprod Biol; 1999 Jul; 85(1):7-11. PubMed ID: 10428315 [TBL] [Abstract][Full Text] [Related]
13. Occurrence of epidermal growth factor receptors in benign and malignant ovarian tumors and normal ovarian tissues: an immunohistochemical study. Henzen-Logmans SC; van der Burg ME; Foekens JA; Berns PM; Brussée R; Fieret JH; Klijn JG; Chadha S; Rodenburg CJ J Cancer Res Clin Oncol; 1992; 118(4):303-7. PubMed ID: 1315781 [TBL] [Abstract][Full Text] [Related]
14. Ki-67 staining in benign, borderline, malignant primary and metastatic ovarian tumors: correlation with steroid receptors, epidermal-growth-factor receptor and cathepsin D. Henzen-Logmans SC; Fieret EJ; Berns EM; van der Burg ME; Klijn JG; Foekens JA Int J Cancer; 1994 May; 57(4):468-72. PubMed ID: 8181851 [TBL] [Abstract][Full Text] [Related]
15. The expression of six biomarkers in the four most common ovarian cancers: correlation with clinicopathological parameters. Lin CK; Chao TK; Yu CP; Yu MH; Jin JS APMIS; 2009 Mar; 117(3):162-75. PubMed ID: 19245589 [TBL] [Abstract][Full Text] [Related]
16. Ovarian mature teratomas with mucinous epithelial neoplasms: morphologic heterogeneity and association with pseudomyxoma peritonei. McKenney JK; Soslow RA; Longacre TA Am J Surg Pathol; 2008 May; 32(5):645-55. PubMed ID: 18344868 [TBL] [Abstract][Full Text] [Related]
17. p63 expression in epithelial ovarian tumors. Poli Neto OB; Candido Dos Reis FJ; Zambelli Ramalho LN; Nogueira AA; de Andrade JM Int J Gynecol Cancer; 2006; 16(1):152-5. PubMed ID: 16445626 [TBL] [Abstract][Full Text] [Related]
18. Telomerase activity in benign and malignant epithelial ovarian tumors. Wan M; Li WZ; Duggan BD; Felix JC; Zhao Y; Dubeau L J Natl Cancer Inst; 1997 Mar; 89(6):437-41. PubMed ID: 9091645 [TBL] [Abstract][Full Text] [Related]
19. Expression profiling of mucinous tumors of the ovary identifies genes of clinicopathologic importance. Wamunyokoli FW; Bonome T; Lee JY; Feltmate CM; Welch WR; Radonovich M; Pise-Masison C; Brady J; Hao K; Berkowitz RS; Mok S; Birrer MJ Clin Cancer Res; 2006 Feb; 12(3 Pt 1):690-700. PubMed ID: 16467078 [TBL] [Abstract][Full Text] [Related]
20. Imbalanced expression of inhibin and activin subunits in primary epithelial ovarian cancer. Zheng W; Luo MP; Welt C; Lambert-Messerlian G; Sung CJ; Zhang Z; Ying SY; Schneyer AL; Lauchlan SC; Felix JC Gynecol Oncol; 1998 Apr; 69(1):23-31. PubMed ID: 9570994 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]